Comment: Reboot biomedical R&D in the global public interest
These concerns pre-date the emergence of the coronavirus SARS-CoV-2, but the pandemic has underscored the urgency of addressing them. That requires looking beyond just one country or sector.
Both public and private interests and investments drive R&D. Research is conducted by public laboratories, universities, private firms , non-profit organizations and health-care facilities . It is funded by taxpayers, philanthropic foundations, private investors, companies and patients. And it is shaped by public policies and agencies, such as those for intellectual property , regulatory standards, procurement, treatment guidelines and reimbursement.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: